NVAX

Novavax
NVAX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.20B
EV
$541.86M
Shares Outstanding
160.84M
Beta
3.14

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$15.17
P/E 2025E
18.04x
P/Revenue 2025E
2.10x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Novavax, Inc.

gainify
NVAX

Novavax, Inc.

NVAX

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technol...

Sector

Healthcare

Industry

Biotechnology

CEO

Jacobs, John

Employees

952

IPO Date

1995-12-05

Headquarters

700 Quince Orchard Road, Gaithersburg, Maryland, 20878, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved